Tisdag 12 November | 13:51:05 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2024-08-26 - Kvartalsrapport 2024-Q2
2024-05-27 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2024-05-24 - Årsstämma
2024-03-13 - Bokslutskommuniké 2023
2023-11-22 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2023-05-26 - Årsstämma
2023-02-17 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-03 - Årsstämma
2022-06-03 - Kvartalsrapport 2022-Q1
2022-06-03 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2022-03-29 - Bokslutskommuniké 2021
2022-02-04 - Extra Bolagsstämma 2022
2021-11-03 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-25 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2021-05-21 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-02-23 - Bokslutskommuniké 2020
2020-11-03 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2020-06-30 - Årsstämma
2020-06-16 - Extra Bolagsstämma 2020
2020-05-12 - Kvartalsrapport 2020-Q1
2020-02-25 - Bokslutskommuniké 2019

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriMedicinteknik
Observe Medical är ett norskt bolag verksamma inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo, Norge.
2024-05-03 12:26:26

Oslo, May 3, 2024 - Observe Medical ASA (OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, May 24, 2024, at 10:00 (CET).

The annual general meeting will be held at Haakon VIIs gt. 1, 7th floor at Reiten & CO, 0161 Oslo, Norway.

The Notice of the Annual General Meeting is attached, together with the attendance, advance vote, and proxy forms.

The Notice is posted electronically or by mail to all shareholders and is available on the company's website www.observemedical.com.

For further information, please contact:

Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, Interim CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics. The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik, Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In addition, Observe Medical has a direct sale organization in the Nordics and a distributor network internationally.

Further information is available at www.observemedical.com.